DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,126 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $915,000 | -27.3% | 5,964 | -31.6% | 0.36% | -2.2% |
| Q3 2019 | $1,259,000 | +2.9% | 8,719 | +1.8% | 0.36% | +0.8% |
| Q2 2019 | $1,224,000 | -4.1% | 8,567 | -11.4% | 0.36% | +5.2% |
| Q1 2019 | $1,276,000 | +26.5% | 9,667 | -1.2% | 0.34% | +13.6% |
| Q4 2018 | $1,009,000 | -34.7% | 9,782 | -31.2% | 0.30% | +49.5% |
| Q3 2018 | $1,545,000 | +11.6% | 14,222 | +1.3% | 0.20% | +3.6% |
| Q2 2018 | $1,385,000 | +1.2% | 14,035 | +0.5% | 0.20% | -5.3% |
| Q1 2018 | $1,368,000 | +6.0% | 13,969 | +0.5% | 0.21% | +17.7% |
| Q4 2017 | $1,290,000 | +8.5% | 13,898 | +0.3% | 0.18% | -2.2% |
| Q3 2017 | $1,189,000 | +1.9% | 13,856 | +0.2% | 0.18% | -4.8% |
| Q2 2017 | $1,167,000 | -1.2% | 13,827 | +0.1% | 0.19% | -4.6% |
| Q1 2017 | $1,181,000 | +10.8% | 13,812 | +0.8% | 0.20% | +2.6% |
| Q4 2016 | $1,066,000 | -1.6% | 13,697 | -0.9% | 0.19% | -5.9% |
| Q3 2016 | $1,083,000 | -21.1% | 13,815 | +1.6% | 0.20% | -23.6% |
| Q2 2016 | $1,373,000 | +6.9% | 13,592 | +0.4% | 0.27% | -1.8% |
| Q1 2016 | $1,284,000 | -5.1% | 13,539 | -7.1% | 0.27% | -3.9% |
| Q4 2015 | $1,353,000 | +10.0% | 14,572 | +1.0% | 0.28% | +10.5% |
| Q3 2015 | $1,230,000 | -5.7% | 14,432 | -5.3% | 0.26% | +7.1% |
| Q2 2015 | $1,305,000 | +15.5% | 15,243 | +14.5% | 0.24% | +3.0% |
| Q1 2015 | $1,130,000 | -0.7% | 13,310 | +0.2% | 0.23% | -0.4% |
| Q4 2014 | $1,138,000 | +19.0% | 13,281 | +5.5% | 0.23% | +7.9% |
| Q3 2014 | $956,000 | +0.3% | 12,588 | +4.0% | 0.22% | -1.8% |
| Q2 2014 | $953,000 | 0.0% | 12,108 | -4.7% | 0.22% | -6.4% |
| Q1 2014 | $953,000 | +3.4% | 12,705 | +6.4% | 0.24% | -1.7% |
| Q4 2013 | $922,000 | +10.3% | 11,941 | -1.0% | 0.24% | +2.1% |
| Q3 2013 | $836,000 | +11.6% | 12,060 | +1.9% | 0.23% | +16.4% |
| Q2 2013 | $749,000 | – | 11,831 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |